Drug Development Archives - Oncology Central Oncology Central

i
i

7 Feb 2019 Clinical trials
Isatuximab meets primary endpoint in Phase III multiple myeloma trial
1 Feb 2019 CAR-T therapy
NICE approves CAR-T therapy Kymriah® for diffuse large B-cell lymphoma in adults
22 Jan 2019 Targeted therapies
Future Oncology: best of 2018
15 Jan 2019 Gastrointestinal
JAVELIN Gastric 100: exploring maintenance avelumab vs first-line chemotherapy in gastric cancer
9 Jan 2019 Chemotherapy
HTX-019 2-min injection shows promise as an alternative method of administration to prevent CINV
6 Dec 2018 News
Palbociclib halts tumor growth in early breast cancer patients
5 Dec 2018 Hematologic
ASH 2018 round-up: practice-changing data for leukemia subtype and more
4 Dec 2018 Personalized medicine
Delays in licensing are denying cancer patients access to innovative treatments
3 Dec 2018 Head and neck
Pembrolizumab extends survival for advanced head and neck cancer patients
30 Nov 2018 Chemotherapy
A three-drug antiemetic regimen including GERSC, rather than palonosetron, may lead to a reduction in the number hydration events required by patients receiving emetogenic chemotherapy
30 Nov 2018 Skin
PD-1 immunotherapy, nivolumab, made available on the NHS for melanoma patients
23 Nov 2018 Lung
Keytruda® gets the green light from NICE for untreated lung cancer